Ruplizumab (BG 9588) 是一种人源化单克隆抗CD40L(TNF Receptor) IgG1κ 抗体。Ruplizumab 具有用于系统性红斑狼疮疾病研究的潜力。
| 生物活性 | Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L(TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1]. |
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com